Health Trials

Other Advanced Solid Tumors

2

Review clinical trials related to Other Advanced Solid Tumors. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study of DXC014 in Patients With Advanced Solid Tumors.

This is a phase I, open-label, first-in-human clinical study designed to evaluate the safety, tolerability, MTD, DLT, RP2D, the PK characteristics, preliminary anti-tumor activity, the immunogenicity of DXC014 in patients with Advanced Solid Tumors.

Participants needed: 150
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Hangzhou DAC Biotechnology Co., Ltd.Updated: Apr 24, 2026Locations: 3
Eligibility criteria

Voluntarily sign the informed consent form and comply with the protocol requirem... [+2]

Within 14 days prior to the first dose: Underwent plasmapheresis; received syste... [+17]

Read more
Status: Recruiting

A Study of SYS6040 for Injection in Patients With Advanced Solid Tumors

This study is the first-in-human Phase I study of SYS6040 for injection, comprising two phases: Dose escalation with backfill (Phase Ia) and cohort expansion (Phase Ib).The planned study population consists of subjects with advanced solid tumors.The objective is to evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of SYS6040 for injection as monotherapy in participants with advanced solid tumors.

Participants needed: 180
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: CSPC Megalith Biopharmaceutical Co.,Ltd.Updated: May 14, 2025Locations: 1
Eligibility criteria

Neutrophil count ≥1.5×109/L; [+5]

Oral fluorouracil agents and small molecule targeted drugs within 2 weeks before... [+20]

Read more